Delivery Order SPE2DB22D1202-SPE2DB24FUVT9

Award Date 4/4/24
Potential Completion Date 4/5/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $3,338.98 and has a performance period through June 14, 2024. The contract is for the procurement of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $4,910.36 and a period of performance through March 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a $13,248.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication, with a completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,318.42, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medical product used for diabetes management. The contract has a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $15,800.86 and a period of performance through November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a $9,842.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a $7,396.24 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 13, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML medication. The contract has a ceiling value of $13,776.75 and a period of performance through April 20, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $2,537.49 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through February 4, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit prime contractor. The contract has a ceiling value of $2,902.80 and a period of performance through April 12, 2024. It is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its Corporate Office division, is an experienced federal...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUVT9
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract is valued at $3,020.49 and has an ultimate completion date of April 5, 2024.

The contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities worldwide in support of the Department of Defense. No set-aside designation was used for this contract.

Generated 7/4/24, 9:36 AM